Inventor · disambiguated record
Eric R. Schuur
Also filed as: SCHUUR ERIC · SCHUUR ERIC R · SCHUUR ERIC RODOLPH
13 granted patents·8 pending applications·637 citations·filing 1995–2025
94Inventor score
Top patents by PatentIndex Score
21 records- 0196US6436394B1Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCELL GENESYS INC·Filed 2000·Granted Aug 20, 2002·90 cites·26 claims
- 0294US5698443ATissue specific viral vectorsCALYDON INC·Filed 1995·Granted Dec 16, 1997·139 cites·12 claims
- 0392US6916918B2Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereofCELL GENESYS INC·Filed 2001·Granted Jul 12, 2005·32 cites·14 claims
- 0492US6585968B2Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereofCELL GENESYS INC·Filed 2001·Granted Jul 1, 2003·36 cites·22 claims
- 0591US5871726ATissue specific and tumor growth supperssion by adenovirus comprising prostate specific antigenCALYDON INC·Filed 1996·Granted Feb 16, 1999·100 cites·32 claims
- 0690US6676935B2Tissue specific adenoviral vectorsCELL GENESYS INC·Filed 1998·Granted Jan 13, 2004·102 cites·31 claims
- 0788US6197293B1Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCALYDON INC·Filed 1998·Granted Mar 6, 2001·54 cites·54 claims
- 0885US7001764B2Compositions comprising tissue specific adenoviral vectorsCELL GENESYS INC·Filed 2002·Granted Feb 21, 2006·14 cites·21 claims
- 0982US6254862B1Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereofCALYDON INC·Filed 1998·Granted Jul 3, 2001·48 cites·63 claims
- 1080US7319033B2Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCELL GENESYS INC·Filed 2002·Granted Jan 15, 2008·9 cites·19 claims
- 1163US2009297483A1Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCELL GENESYS INC·Filed 2007·Application pending·0 cites
- 1259US2004241857A1Tissue specific adenoviral vectorsFiled 2004·Application pending·0 cites
- 1357US2025312382A1Cell Therapy for Treating Liver DiseaseHEPATX CORP·Filed 2025·Application pending·0 cites
- 1450US2002068049A1Tissue specific adenoviral vectorsFiled 2000·Application pending·0 cites
- 1549US2003039990A1Non-destructive cell-based assayFiled 2001·Application pending·0 cites
- 1644US6051417AProstate cancer drug screening using hKLK2 enhancerCALYDON INC·Filed 1997·Granted Apr 18, 2000·7 cites·11 claims
- 1744US2025102522A1Methods of tracking donor cells in a recipientHEPATX CORP·Filed 2022·Application pending·0 cites
- 1844US2003026792A1Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereofFiled 2001·Application pending·0 cites
- 1943US2006165658A1Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereofLITTLE ANDREW S·Filed 2005·Application pending·0 cites
- 2040US7011976B1Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereofCELL GENESYS INC·Filed 1998·Granted Mar 14, 2006·3 cites·10 claims
- 2136US5783435AProstate cancer drug screeningsFiled 1996·Granted Jul 21, 1998·3 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Eric R. Schuur files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →